Atherosclerosis and angiogenesis: What do nerves have to do with it?

Pharmacological Reports

Volumn 57, Issue SUPPL., 2005, Pages 229-234

  Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Dipeptidyl peptidase IV; Endothelium; Ischemia; Neuropeptide Y; NPY receptors; Restenosis

Indexed keywords

APPETITE STIMULANT; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GROWTH FACTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; VASOCONSTRICTOR AGENT;

ADRENERGIC TRANSMISSION; ANGIOGENESIS; ANGIOPLASTY; ATHEROGENESIS; ATHEROSCLEROSIS; DRUG TARGETING; HUMAN; HYPERPLASIA; ISCHEMIA; LIMB BLOOD FLOW; LIMB ISCHEMIA; NERVE; NEURAL STEM CELL; NONHUMAN; PLEIOTROPY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR UPREGULATION; RESTENOSIS; REVASCULARIZATION; REVIEW; RODENT; SMOOTH MUSCLE FIBER; STRESS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 33645684338     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bao L, Kopp J, Zhang X, Xu ZQ, Zhang LF, Wong H, Walsh J, Hokfelt T: Localization of neuropeptide Y Y1 receptors in cerebral blood vessels. Proc Natl Acad Sci USA, 1997, 94, 12661-12666.
2. Battegay EJ: Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med, 1995, 73, 333-346.
3. Berglund MM, Schober DA, Esterman MA, Gehlert DR: Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther, 2003, 307, 1120-1126.
4. Deindl E, Schaper W: The art of arteriogenesis. Cell Biochem Biophys, 2005, 43, 1-16.
5. Dinger MC, Bader JE, Kobor AD, Kretzschmar AK, Beck-Sickinger AG: Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem, 2003, 278, 10562-10571.
6. Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS: Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation, 2004, 109, 2826-2831.
7. Erlinge D, Brunkwall J, Edvinsson L: Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept, 1994, 50, 259-265.
8. Flugelman MY, Virmani R, Correa R, Yu ZX, Farb A, Leon MB, Elami A et al.: Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation, 1993, 88, 2493-2500.
9. Folkman J: Therapeutic angiogenesis in ischemic limbs. Circulation, 1998, 97, 1108-1110.
10. Ghersi G, Chen W, Lee EW, Zukowska Z: Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides, 2001, 22, 453-458.
11. Hansel DE, Eipper BA, Ronnett GV: Neuropeptide Y functions as a neuroproliferative factor. Nature, 2001, 410, 940-944.
12. Kaijser L, Pernow J, Berglund B, Lundberg JM: Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clin Physiol, 1990, 10, 179-188.
13. Kallio J, Pesonen U, Kaipio K, Karvonen MK, Jaakkola U, Heinonen OJ, Uusitupa MI, Koulu M: Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. Faseb J, 2001, 15, 1242-1244.
14. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS: Control of feeding and sexual behaviors by neuropeptide Y: physiological implications. Synapse, 1988, 2, 254-257.
15. Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM et al.: Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med, 1998, 4, 1434-1437.
16. Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J et al.: Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res, 2005, 65, 1719-1728.
17. Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, Pesonen U, Geng Y et al.: Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med, 2004, 36, 232-240.
18. Laham RJ, Garcia L, Baim DS, Post M, Simons M: Therapeutic angiogenesis using basic fibroblast growth factor and vascular endothelial growth factor using various delivery strategies. Curr Interv Cardiol Rep, 1999, 1, 228-233.
19. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA et al: Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation, 1996, 94, 1074-1082.
20. Lee EW, Grant DS, Movafagh S, Zukowska Z: Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides, 2003, 24, 99-106.
21. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A et al.: Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest, 2003, 111, 1853-1862.
22. Li L, Jonsoon-Rylander AC, Abe K, Zukowska Z: Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arterioscler Thromb Vasc Biol, 2005, 25, 2075-2080.
23. Li L, Lee EW, Ji H, Zukowska Z: Neuropeptide y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol, 2003, 23, 1204-1210.
24. Matsuda H, Brumovsky PR, Kopp J, Pedrazzini T, Hokfelt T: Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues. J Comp Neurol, 2002, 449, 390-404.
25. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature, 1993, 362, 844-846.
26. Nilsson T, Edvinsson L: Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors. Can J Physiol Pharmacol, 2000, 78, 256-259.
27. Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M, Rauramaa R et al.: Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab, 2000, 85, 2266-2269.
28. Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z: Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol, 2003, 81, 177-185.
29. Pons J, Lee EW, Li L, Kitlinska J: Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases. Curr Opin Investig Drugs, 2004, 5, 957-962.
30. Scheinowitz M, Shou M, Banai S, Gertz SD, Lazarous DF, Unger EF: Neointimal proliferation in canine coronary arteries. A model of restenosis permitting local and continuous drug delivery. Lab Invest, 1994, 71, 813-819.
31. Wahlestedt C, Hakanson R, Vaz CA, Zukowska-Grojec Z: Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am J Physiol, 1990, 258, R736-742.
32. Zukowska Z, Grant DS, Lee EW: Neuropeptide y. A novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med, 2003, 13, 86-92.
33. Zukowska Z, Pons J, Lee EW, Li L: Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol, 2003, 81, 89-94.
34. Zukowska-Grojec Z: Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci, 1995, 771, 219-233.
35. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA, Ji H: Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept, 1998, 75-76, 231-238.
36. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y et al.: Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res, 1998, 83, 187-195.
37. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK, Wahlestedt C: Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides, 1993, 14, 263-268.
38. Zukowska-Grojec Z, Wahlestedt C: Origin and actions of neuropeptide Y in the cardiovascular system. In: The Biology of Neuropeptide Y and Related Peptides. Ed. Colmers WF, Wahlestedt C, Human Press, Totowa, 1993, 315-388.